SCHEMBL1380

SCHEMBL1380

Cn1[c]ccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3249847 0.60
SCHEMBL4927956 0.58
SCHEMBL9549440 0.47 INMT (0.37)
SCHEMBL7269741 0.47
SCHEMBL31175398 0.46
SCHEMBL18773169 0.46
SCHEMBL10017669 0.39
Benzene SCHEMBL29650150 0.39
Benzene SCHEMBL29757764 0.39 TSHR (0.75)
Benzene SCHEMBL5314229 0.35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6156 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240199679-A1 ADENOSINE DERIVATIVE HAVING ANTAGONISTIC ACTION ON A2A AND A3 ADENOSINE RECEPTORS AND METHOD FOR PREPARING SAME FUTURE MEDICINE CO., LTD. (KR) 2024-06-20 US claimed
EP-4382101-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS Eurofarma Laboratórios S.A. (BR) 2024-06-12 EP claimed
CN-118076347-A N-acylhydrazone compounds capable of inhibiting NAV 1.7 and/or NAV 1.8, methods of making, compositions, uses, methods of treatment and kits using the same 欧罗法玛实验室股份公司 2024-05-24 CN claimed
US-20240109916-A1 CYTOTOXIC AGENTS PHEON THERAPEUTICS LTD (GB) 2024-04-04 US claimed
CN-117658982-A Novel CDK12/13 covalent inhibitor or pharmaceutical composition and application thereof 中国科学院上海有机化学研究所 2024-03-08 CN claimed
EP-4296273-A1 ADENOSINE DERIVATIVE HAVING ANTAGONISTIC ACTION ON A2A AND A3 ADENOSINE RECEPTORS AND METHOD FOR PREPARING SAME Future Medicine Co., Ltd. (KR) 2023-12-27 EP claimed
CN-113861103-B Method for synthesizing pyridine, bipyridine and terpyridine ligand 南方科技大学 2023-12-22 CN claimed
US-11827632-B2 NLRP3 modulators INNATE TUMOR IMMUNITY, INC (US) 2023-11-28 US claimed
CN-117083286-A Pair A 2A A is a 3 Adenosine derivatives having antagonism to adenosine receptor and process for preparing same 未来制药有限公司 2023-11-17 CN claimed
US-20230339866-A1 Quinazoline compounds and the use thereof in the treatment of cancer TroBio Therapeutics Pty Ltd (AU) 2023-10-26 US claimed
US-4355823-A Pressure-sensitive or heat-sensitive recording material CIBA-GEIGY CORPORATION (US) 1982-10-26 US claimed
EP-0049999-A2 Cyclic compounds and their preparation and use BEECHAM GROUP PLC (GB) 1982-04-21 EP claimed
US-4304779-A 6-(Nitrogen-containing heterocyclic)hydroxymethylpenicillanic acids, compounds related thereto and processes for their preparation SCHERING CORPORATION (US) 1981-12-08 US claimed
US-4269773-A CEPHALOSPORINS SHIONOGI & CO., LTD. (JP) 1981-05-26 US claimed
US-4252807-A Fused pyrimidine derivatives and antiatherosclerotic methods of treatment with them CHINCIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) 1981-02-24 US claimed
EP-0005014-A1 Clavulanic acid derivatives, preparation and compositions BEECHAM GROUP PLC (GB) 1979-10-31 EP claimed
US-4048171-A 1,4-Dihydropyridines BAYER AKTIENGESELLSCHAFT (DT) 1977-09-13 US claimed
US-4031226-A ANTIEMETIC, PSYCHOTROPIC JANSSEN PHARMACEUTICA N.V. (BE) 1977-06-21 US claimed
US-3998834-A ANALGESICS JANSSEN PHARMACEUTICA N.V. (BE) 1976-12-21 US claimed
US-3957993-A ADMINISTERING MCNEIL LABORATORIES, INCORPORATED (US) 1976-05-18 US claimed